Kadyrova Lyudmila Y, Dahal Basanta K, Kadyrov Farid A
From the Department of Biochemistry and Molecular Biology, Southern Illinois University, School of Medicine, Carbondale, Illinois 62901.
From the Department of Biochemistry and Molecular Biology, Southern Illinois University, School of Medicine, Carbondale, Illinois 62901
J Biol Chem. 2016 Dec 30;291(53):27298-27312. doi: 10.1074/jbc.M116.760561. Epub 2016 Nov 21.
The DNA mismatch repair (MMR) system corrects DNA mismatches in the genome. It is also required for the cytotoxic response of O-methylguanine-DNA methyltransferase (MGMT)-deficient mammalian cells and yeast mgt1Δ rad52Δ cells to treatment with S1-type methylating agents, which produce cytotoxic O-methylguanine (O-mG) DNA lesions. Specifically, an activity of the MMR system causes degradation of irreparable O-mG-T mispair-containing DNA, triggering cell death; this process forms the basis of treatments of MGMT-deficient cancers with S1-type methylating drugs. Recent research supports the view that degradation of irreparable O-mG-T mispair-containing DNA by the MMR system and CAF-1-dependent packaging of the newly replicated DNA into nucleosomes are two concomitant processes that interact with each other. Here, we studied whether CAF-1 modulates the activity of the MMR system in the cytotoxic response to S1-type methylating agents. We found that CAF-1 suppresses the activity of the MMR system in the cytotoxic response of yeast mgt1Δ rad52Δ cells to the prototypic S1-type methylating agent N-methyl-N'-nitro-N-nitrosoguanidine. We also report evidence that in human MGMT-deficient cell-free extracts, CAF-1-dependent packaging of irreparable O-mG-T mispair-containing DNA into nucleosomes suppresses its degradation by the MMR system. Taken together, these findings suggest that CAF-1-dependent incorporation of irreparable O-mG-T mispair-containing DNA into nucleosomes suppresses its degradation by the MMR system, thereby defending the cell against killing by the S1-type methylating agent.
DNA错配修复(MMR)系统可校正基因组中的DNA错配。O-甲基鸟嘌呤-DNA甲基转移酶(MGMT)缺陷的哺乳动物细胞和酵母mgt1Δ rad52Δ细胞对S1型甲基化剂治疗产生细胞毒性反应时也需要该系统,S1型甲基化剂会产生细胞毒性的O-甲基鸟嘌呤(O-mG)DNA损伤。具体而言,MMR系统的一种活性会导致含有无法修复的O-mG-T错配的DNA降解,从而引发细胞死亡;这一过程构成了用S1型甲基化药物治疗MGMT缺陷型癌症的基础。最近的研究支持这样一种观点,即MMR系统对含有无法修复的O-mG-T错配的DNA的降解以及CAF-1依赖的将新复制的DNA包装到核小体中是两个相互作用的伴随过程。在这里,我们研究了CAF-1是否在对S1型甲基化剂的细胞毒性反应中调节MMR系统的活性。我们发现,在酵母mgt1Δ rad52Δ细胞对原型S1型甲基化剂N-甲基-N'-硝基-N-亚硝基胍的细胞毒性反应中,CAF-1抑制了MMR系统的活性。我们还报告了证据表明,在人MGMT缺陷的无细胞提取物中,CAF-1依赖地将含有无法修复的O-mG-T错配的DNA包装到核小体中会抑制MMR系统对其的降解。综上所述,这些发现表明,CAF-1依赖地将含有无法修复的O-mG-T错配的DNA整合到核小体中会抑制MMR系统对其的降解,从而保护细胞免受S1型甲基化剂的杀伤。